CIK 0001649094 · Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464233385
- Phone
- 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 3 Insider Initial Statement of Ownership
- PRE 14A Proxy Proxy Statement (Preliminary)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- UPLOAD Other SEC-generated Letter
- 4 Option exercise Director acquired 7,000 shares (option exercise)
- 4 Option exercise PRESIDENT AND CFO acquired 4,777 shares (option exercise)
- 4 Option exercise CHIEF EXECUTIVE OFFICER acquired 20,533 shares (option exercise)
- 8-K Event Regulation FD disclosure · Other events
- 4 Planned sale SVP, GEN COUNSEL & CORP SEC sold 5,000 shares at an average $70.74 ($353,699)
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes PRESIDENT AND CFO gave up 5,079 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, FINANCE gave up 567 shares (to pay taxes)
Page 9 of 39 · 770 filings